Business ❯ Finance ❯ Mergers and Acquisitions ❯ Valuation

Market Impact

Gilead to Acquire Arcellx for Up to $7.8 Billion to Gain Full Control of CAR-T Anito-Cel

The purchase secures full control of anito-cel, a BCMA-directed cell therapy under FDA review with a December 23 action date.

Harman to Buy ZF’s Passenger-Car ADAS Unit for €1.5 Billion

Marvell to Acquire Celestial AI for $3.25 Billion to Bring Photonics In‑House